Larimar Therapeutics (LRMR) Shares Issued (2016 - 2020)
Historic Shares Issued for Larimar Therapeutics (LRMR) over the last 6 years, with Q4 2020 value amounting to $242000.0.
- Larimar Therapeutics' Shares Issued fell 9299.57% to $242000.0 in Q4 2020 from the same period last year, while for Dec 2020 it was $18.1 million, marking a year-over-year decrease of 666.19%. This contributed to the annual value of $161.8 million for FY2024, which is 53925333.33% up from last year.
- Larimar Therapeutics' Shares Issued amounted to $242000.0 in Q4 2020, which was down 9299.57% from -$135000.0 recorded in Q3 2020.
- Over the past 5 years, Larimar Therapeutics' Shares Issued peaked at $64.2 million during Q3 2018, and registered a low of -$135000.0 during Q3 2020.
- Its 5-year average for Shares Issued is $6.0 million, with a median of $261000.0 in 2018.
- Its Shares Issued has fluctuated over the past 5 years, first skyrocketed by 8016625.0% in 2018, then tumbled by 10135.69% in 2020.
- Quarter analysis of 5 years shows Larimar Therapeutics' Shares Issued stood at $165000.0 in 2016, then crashed by 51.52% to $80000.0 in 2017, then skyrocketed by 275.0% to $300000.0 in 2018, then skyrocketed by 1051.67% to $3.5 million in 2019, then plummeted by 93.0% to $242000.0 in 2020.
- Its Shares Issued was $242000.0 in Q4 2020, compared to -$135000.0 in Q3 2020 and $8.4 million in Q2 2020.